Don’t see your insurance company listed?
You can also download a template letter that you can customize and send to your specific insurer. On most insurance company websites, you can find a ‘contact us’ page or a similar page with directions on where to send your letter.
While insurance companies offering #Coverage2Control include insulin on their preventive medicine list, insurers can take at least three additional steps to help keep out-of-pocket costs for insulin even more predictable and reasonable. These include:
- Passing rebates received on pharmaceuticals to beneficiaries in the form of reduced prices.
- Moving insulin and diabetes management tools to tier 1 or tier 2 benefit levels.
- Providing cost-sharing for insulin and diabetes management tools as fixed dollar “co-payments” rather than a percentage “co-insurance.””
For example, UnitedHealthcare recently announced it will extend the pharmacy discounts it receives – including for insulin – to millions of its members. Blue Cross Blue Shield Florida has also taken significant positive steps on these policies. They offer zero cost-sharing for insulin pumps and pump supplies for those under age 65 and their brand drugs for diabetics are half the cost of other brands in the same tier of their formulary. They also make sure that insulin is on their preventive medicine list in all individual and small group plans. JDRF is interested to hear from other insurance companies on their policies around insulin affordability — please contact us.
**Emblem considers upgrades to the 670G artificial pancreas system on a case-by-case basis.
Note: The information in the above table reflects publicly available documents or responses to emailed requests for information from each health insurance company. Each company offers a number of health plans, some of which may have different coverage policies than are shown here.
For insurance companies: Any insurance company who would like to contact JDRF about its health plan offerings or the information in the chart above, please contact Jesse Bushman, JDRF’s Senior Director of Healthy Policy.